Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Leukocyte count is an independent predictor of future long COVID in postmenopausal women, according to study findings.

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the US President's Emergency Plan for AIDS Relief.

Kansas health officials are tackling the largest tuberculosis outbreak in US history, with 67 confirmed cases since the start of 2025.

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to study findings.

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at 5 and 10 years.